2-[(3R,4S,5S,6S)-6-acetyl-3-acetyloxy-4,5-dimethyloxan-2-yl]oxy-5-(acetyloxymethyl)benzoic acid
C21H26O9 — CID 158304934
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3R,4S,5S,6S)-6-acetyl-3-acetyloxy-4,5-dimethyloxan-2-yl]oxy-5-(acetyloxymethyl)benzoic acid
2-[(3R,4S,5S,6S)-6-acetyl-3-acetyloxy-4,5-dimethyloxan-2-yl]oxy-5-(acetyloxymethyl)benzoic acid (PubChem CID 158304934) has the molecular formula C21H26O9 and a molecular weight of 422.43 g/mol. Its IUPAC name is 2-[(3R,4S,5S,6S)-6-acetyl-3-acetyloxy-4,5-dimethyloxan-2-yl]oxy-5-(acetyloxymethyl)benzoic acid.
Molecular Properties
| Compound Name | 2-[(3R,4S,5S,6S)-6-acetyl-3-acetyloxy-4,5-dimethyloxan-2-yl]oxy-5-(acetyloxymethyl)benzoic acid |
|---|---|
| PubChem CID | 158304934 |
| Molecular Formula | C21H26O9 |
| Molecular Weight | 422.43 g/mol |
| Exact Mass | 422.16 |
| IUPAC Name | 2-[(3R,4S,5S,6S)-6-acetyl-3-acetyloxy-4,5-dimethyloxan-2-yl]oxy-5-(acetyloxymethyl)benzoic acid |
| SMILES | CC(=O)OCc1ccc(OC2O[C@H](C(C)=O)[C@@H](C)[C@H](C)[C@H]2OC(C)=O)c(C(=O)O)c1 |
| InChI | InChI=1S/C21H26O9/c1-10-11(2)19(28-14(5)24)21(30-18(10)12(3)22)29-17-7-6-15(9-27-13(4)23)8-16(17)20(25)26/h6-8,10-11,18-19,21H,9H2,1-5H3,(H,25,26)/t10-,11-,18-,19+,21?/m0/s1 |
| InChIKey | FQLODOSPCWQBFQ-RWFJZONWSA-N |
| XLogP | 2.34 |
| TPSA | 125.43 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.43 |
| LogP ≤ 5 | 2.34 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158304934 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.